{
    "2021-03-25": [
        [
            {
                "time": "2021-03-22",
                "original_text": "AstraZeneca (AZN) Reports New Efficacy Data on COVID-19 Vaccine",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "efficacy",
                        "COVID-19",
                        "vaccine"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-26",
                "original_text": "UPDATE 1-Thailand approves Johnson & Johnson's COVID-19 vaccine",
                "features": {
                    "keywords": [
                        "Thailand",
                        "approves",
                        "Johnson & Johnson",
                        "COVID-19",
                        "vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Did You Participate In Any Of Johnson & Johnson's (NYSE:JNJ) Respectable 70% Return?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "return",
                        "investors"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "AstraZeneca Revises COVID-19 Vaccine Efficacy To 76% After Controversy",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "revises",
                        "efficacy",
                        "COVID-19",
                        "vaccine",
                        "controversy"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}